STARPHARMA HLDG.SP.ADR/10 Working Capital to Net Assets Ratio
STARPHARMA HLDG.SP.ADR/10 working capital to net assets ratio. STARPHARMA HLDG.SP.ADR/10 (PQ6A) has a Working Capital to Net Assets ratio of 91.2% as of June 2025. Working capital of €17.33 Million (current assets of €22.56 Million minus current liabilities of €5.23 Million) is measured against net assets of €19.00 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is STARPHARMA HLDG.SP.ADR/10's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of STARPHARMA HLDG.SP.ADR/10 (2022–2025)
Working capital to net assets ratio of STARPHARMA HLDG.SP.ADR/10 from 2022 to 2025. This chart shows how STARPHARMA HLDG.SP.ADR/10's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2022 to 2025. As of June 2025, the ratio stands at 91.2%, reflecting working capital of €17.33 Million against net assets of €19.00 Million EUR. See STARPHARMA HLDG.SP.ADR/10 defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
STARPHARMA HLDG.SP.ADR/10 Working Capital to Net Assets Ratio by Year (2022–2025)
STARPHARMA HLDG.SP.ADR/10 working capital to net assets ratio by year from 2022 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for STARPHARMA HLDG.SP.ADR/10 from 2022 to 2025, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see STARPHARMA HLDG.SP.ADR/10 balance sheet assets.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 91.2% | €17.33 Million | €19.00 Million | €22.56 Million | €5.23 Million | ▼ -2.1 pp |
| 2024 | 93.4% | €26.26 Million | €28.12 Million | €32.92 Million | €6.66 Million | ▼ -0.4 pp |
| 2023 | 93.8% | €32.65 Million | €34.81 Million | €47.12 Million | €14.47 Million | ▼ -10.4 pp |
| 2022 | 104.2% | €50.43 Million | €48.39 Million | €60.66 Million | €10.23 Million | — |